Empagliflozin and dulaglutide: community awareness project promotes improved access to newly funded medications for Pacific patients with type 2 diabetes.

Sundborn, Gerhard; Lesa, Fale; King, Graham; Vennell, Kate; Kozak, Henry; Pickering, Karen; Baker, John

Sundborn, Gerhard; Lesa, Fale; King, Graham; Vennell, Kate; Kozak, Henry; Pickering, Karen; Baker, John.

Afiliación

Sundborn G; Senior Lecturer, Section of Pacific Health School of Population Health, Faculty of Medical and Health Sciences, The University of Auckland.
Lesa F; Board Member, Diabetes Foundation Aotearoa.
King G; Board Member, Diabetes Foundation Aotearoa.
Vennell K; Board Member, Diabetes Foundation Aotearoa.
Kozak H; Board Member, Diabetes Foundation Aotearoa.
Pickering K; General Manager, Board Member, Diabetes Foundation Aotearoa.
Baker J; Clinical Director, Middlemore Clinical Trials, Auckland.

N Z Med J ; 136(1572): 66-74, 2023 Mar 24.

Article en En | MEDLINE | ID: mdl-36958323

Asunto(s)

Diabetes Mellitus Tipo 2; Humanos; Diabetes Mellitus Tipo 2/tratamiento farmacológico; Nueva Zelanda; Hipoglucemiantes/uso terapéutico

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: N Z Med J Año: 2023 Tipo del documento: Article

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links